Q2 Highlights
Our quarterly review with key highlights across Tech to help you connect better to our story and change journey.
#TechTogether
Delivering our IPTc strategy
Tech Transformation
Innovation in Biopharma
Trust in cyber security
Global Tech
GSK Global Tech Q2 2021 Highlights July 2021
Tech continues to be the headlights of GSK, lighting the way as we future proof our technology to create value and reduce cycle time to launch new products. All our work is underpinned by our people and culture.
See more inside
Back to top
We continue to work closely with our partners to grow our teams in the GCCs while prioritising our personal development by hosting our second Skills Development Week. Veeva QMS and OneCDS went live and are starting to make an impact (they are not just acronyms…)
Transforming ourselves
We achieved a landmark milestone of 100% ERP coverage, hosted our first DataCon and delivered our first phase of PIE using Code Orange. ServiceNow continues to be rolled out across GSF and our R&D Clinical Control Tower went live.
Transforming others
Our innovative and future-back thinking shown through our Demo Days and Masterclasses, hosted by Beyond, starts to take centre stage as we enable Q-Block at Barnard Castle to maximise yield and reduce waste. We also use Digital Twin for the first time to support respiratory supply chain and predict the size of liposomes.
Every one of us has a responsibility to help keep GSK secure and Trust is our key priority. Our Tech team have run phishing simulations, updated our software and protected us from the ever evolving and ongoing daily cyber-attacks.
We’ve progressed our Cosmos integration in EMEA, Brazil and our manufacturing sites, and we’re accelerating our focus on separation. We have around 1,200 apps, 1,100 business processes and over 4,000 interfaces in scope to separate. The big focus for Q3 for Process & System Separation is UAT readiness and cutover planning.
Integration & Separation
AI/ Machine Learning
Reclaim Your Voice
The CH Tech and GB Expert Marketing team have partnered with an external agency to develop the first speech therapy app for denture wearers – Reclaim Your Voice. The mobile app is powered by AI voice diagnostics and helps the denture wearers retrain their mouth with a series of simple, daily speech exercises. They receive personalised feedback and can track their ongoing progress. Learn more Contact: Adam Hurst
The Energy Consumption Visualisation allows Energy Managers on sites to reduce CO2 emissions. We need data to do this effectively. Currently, the energy meters at our sites are read manually and the process to get the data to the Corporate Network is a long and arduous process. In order to create usable data, we have been experimenting with Remote Telemetry to create a direct data feed available to the Azure Cloud, which will send energy meter readings directly to SFTP using cellular network more quickly. Learn more Contact: Michael Smorti and Chris Yates
Tracking our packaging sustainability effort
Japan project Origami
CH Tech joined forces with the Packaging team to build Packaging Sustainability BI – Origami, to track the progress of our effort and to identify opportunities for a sustainable packaging as a responsible company that delivers everyday health with humanity. The team delivered an MVP leveraging Azure and Power BI, embedding business processes in a 12-week sprint with the Japan market and are preparing to scale to other markets in Q3/Q4 2021. Learn more Contact: Satoshi Ogawa and Midya Nafadini
In Quality Supply Chain, the New Product Introduction process was complex, manual and repetitive. The NPI Programme has reduced the lead time between Champs site initiation and the end of SIA by 50% at Oak Hill. Learn more Contact: Andreas Rassau
New Product Introduction (NPI)
We designed a new website for HCPs and localised it for different markets. This improved user experience has seen a significant increase in engagement, with HCPs spending more time browsing the site which has improved SEO. To enable us to replicate success, we created many reusable web components which can be scaled easily and re-used for other websites. We also removed custom code so we now have a modern, global, reusable design. Contact: Marek Wagner
Launch of ViiV Exchange V.2
GSK successfully set up a foundation of transformative new cutting-edge technologies such as AI/ML to enhance the patient experience and support the salesforce. By combining advanced predictive patient analytics and Next Best Action, customer-facing teams are receiving timely and highly accurate insights to support their conversations with HCPs about Blenrep as an appropriate treatment option. To date, a 56% increase in Blenrep prescribing has been realised where reps have engaged specific HCPs as a result of the predictive patient insights. ViiV teams in the UK and Spain are also benefiting from the NBA tool MARTii, to make data-driven decisions and provide a more personalised experience for their customers. Contact: Eric Moe and Madhavi Ramakrishna
NBA and US Blenrep
Atlas
In partnership with the government and local hospitals, we established the first Coronary Obstructive Pulmonary Disorder (COPD) patient support programme as part of a disease management digital healthcare eco-system in Yin Chuan, China. This will meet the unmet need of awareness, diagnosis and treatment compliance. This digital patient support program is powered by 5G Internet of Things and big data, and supported by advanced design and technology. Learn more Contact: Kevin Li
The first COPD digital healthcare eco-system in Yin Chuan, China
The CRMS team have been working with Ipsos MORI to generate consumer insights through conducting interviews with real consumers, who are contacting GSK with problems and feedback. Contact: Marko Ivanovic
CRMS consumer listening
Preparing for employee return to office
As local government COVID-19 pandemic restrictions and access to GSK sites begin to lift, a joint team from Core Tech and WREF are making plans and preparations. COVID-19 has changed the ways in which we work either at home or in the office. The Return to Office teams has been gathering information based on employee experience, research and direct feedback. The team have identified priority focus areas to help optimise the employee experiences at seven core sites (UP, STV, GSK House, WAV/RIX, Asia House, Poznan). Learn more Contact: Darwin Johnson
When the pandemic in India took hold, we helped provide support to GSK employees, partners and their immediate families. GSK has procured oxygen concentrators to be used by immediate family members of employees/partners and Core Tech volunteers helped with vaccination drives, collaborated with ambulatory services, provided hospital beds, and more. Throughout, we continued our focus on business continuity, productivity and planning for shifting workloads to other geographies and progressed on the timely deliverables, knowledge transition and execution of critical activities and applications with our strategic partner, HCL. Learn more Contact: Hapreet Bedi
Our response to the COVID outbreak in India
We launched the new CH Culture across CH Digital & Tech: Go beyond, do what matters most and keep it human. Over the next few months, we’ll explore the behaviours in three phases through team experimentation. Learn more Contact: Emma Douglas and Pippa Harris
Culture kick-off
Lead time reduced by
50%
Advances in technology are rapidly increasing our ability to capture, analyse and share data, allowing us to generate scientific knowledge at an unprecedented pace. R&D Portfolio Management took a big step forward with delivery of Atlas – a DDA application within the R&D Data Marketplace. This will bring together all scientific knowledge generated in Research, Oncology, Global Health and Medicinal Science & Technology. Atlas will enable us to increase productivity by improving decision making, reducing cycle times and accelerating delivery of innovative medicines to patients. Learn more Contact: Chuck Smith
Home Delivering our IPTc Transforming ourselves Transforming others Integration & Separation Innovation Trust
This is a unique programme bringing together GSK, a GSK-Tech partner (Cognizant) and an NGO (AMREF) in a collaboration to deliver a high-impact, needed solution to integrate tech platforms used by health workers across Africa. This is the first attempt at a multi-stakeholder programme, convening experts who are jointly committed to outcomes, and who contribute unique skills to the programme delivery. Contact: Francois Flavard-Jones
Part of the Global Health Initiative, first tripartite philanthropic co-investment finalised
£194.5M, five-year Enterprise agreement signed with Microsoft
In this agreement, we have an opportunity to reimagine and become a digital business with the strength, resilience, and discipline to compete at a time when the healthcare and life sciences industry is in a period of significant change – including disruption from innovative tech start-ups and established tech vendors. We continue to focus on culture while using science and technology to tackle some of the biggest global health challenges and delivering leading scientific and medical engagement. Digital technology is transforming how we develop new medicines, vaccines, and consumer healthcare products and how we interact with customers. Applying digital technology across our value chain is vital to address these challenges, and our strategic partnership with Microsoft is key to delivering this transformation. Contact: Jasdeep Sandhu
Launched the first GSK China CH daily dashboard
This new dashboard provides the China General Manager and leadership team with a holistic view of three new Business Units; and online and offline channel visibility to support timely sell in performance review. Learn more Contact: Bing Liu
The CH Veeva QMS (Quality Management System) journey began back in January 2020 and less than 18 months later, we are now live. It enhances our ability to optimise and work together globally on our quality processes. Learn more Contact: Andreas Rassau, Chris Stanco and Don Bodinger
Veeva QMS goes live
Launched our own CH Agile Methodology: Amplify
Amplify has been designed by and for GSK Consumer Healthcare. This is a living document that is the foundation of how we want to work in CH Digital & Tech in the future. It describes how we want our teams to work together, how we want to deliver our work, prioritise what is most important, and how we want to operate. We have squads of coaches to provide on-the-ground coaching, an Amplify site and supporting Workplace group, while supporting leaders with the deployment of new squads and share best practice. Learn more Contact: Amy Houston
In June, we launched Batch Release Hub, a GMP tool to help Supply Chain understand issues holding up batches. The tool currently pulls data from SAP and OPAL in a format that can be easily understood to compliantly and speedily perform batch release. Learn more Contact: Graham McCauley
Batch Release Hub
The first Serialisation Track & Trace integration, across US Pharma Supply Chain and US Commercial, was reached 18 months ahead of the FDA Drug Supply Chain Security Act (DSCSA) target date. It allows the tracking of GSK products from the manufacturing site all the way through to the patient, securing the supply chain and enhancing patient safety. Learn more Contact: Cammy McKinnell
US Track & Trace pilot complete
OneCDS empowering all sites upgraded to FR4 globally
With many hours of hardware installation and creation of new Empower projects, we’ve fully implemented OneCDS, a supporting system that directly connects our chromatography equipment to our Lab Execution System (LES). LES is a business initiative to support paperless operations and QC, directly eliminating transcription errors and paper documentation. Learn more Contact: Ed Murphy
We launched the refreshed Brilliant Managers programme in June during Skills Development Week. It’s flexible programme design provides managers, grade 3-8, with practical everyday tools and techniques to support them to be the best leaders they can be. Based on initial feedback, 379 participants have already found value in the programme and 97% of attendees would recommend it to other leaders. In addition, 200+ managers signed up to a Peer Coaching pilot, where they were connected to a peer in their Tech leadership network to reinforce learnings from the workshops and to help them strengthen personal values, impact and relationships at work. Learn more Contact: Ahsiya Mencin
Brilliant Managers programme
Skills Development Week #2 hosted 46 events covering 28 topics across all global time zones with 2,342 event attendees. Tech colleagues got the opportunity to get ‘hands on’ with labs, scenarios, games and events hosted by GSK colleagues and strategic partners on Tech’s key skills capabilities: Cloud technology; Data Engineering and Data Science; Product Management and Product design. 75% of 165 survey responders stated they could apply their skills straight away. Learn more Contact: Lee Broomhall
Skills Development Week 2
Events
46
Topics
28
Event attendees
2,342
Landmark milestone of 100% ERP coverage coming up and end of ERP programmes
After deploying ERP to 169 global markets across CH, ViiV and Rx along with 46 manufacturing sites, and integrating 50 Pfizer CH markets (including three sites), we now have only Egypt CERPs and one Pfizer CH site to complete by September 2021. This means we are incredibly close to finishing a landmark milestone and journey for GSK, which will result in 100% of total global revenue running through the platform with ~ 93k CERPS and ~18k MERP users. Standardisation and simplification of one instance has been a game-changer for the joint venture integrations and is a significant enabler for the work we are currently doing to transform and separate our businesses. Cash analytics value strikes, for example, has already improved our cash position by over £200m. Our ongoing continuous improvement efforts will also benefit from having a robust, rigorous and well controlled system as the base platform for the business. There is no doubt having a single instance across GSK contributed as an enabler in response to the pandemic, allowing us to meet our reporting requirements effectively without missing a beat. Learn more Contact: Jon Jacobs
As we continue our service management transformation for GSK, HR Americas joined Tech and were successfully onboarded to the ServiceNow platform on 4 May, supporting around 30K employees. HR are already seeing a behaviour shift to ‘self-service’ among Americas employees, as they use the Service Portal for their HR queries and requests, in line with anticipated volumes. The ServiceNow team are now getting ready for next go-live in August which will see multiple GSFs onboard to the Service Portal including HR Asia-Pac, UK, Ireland, South Africa and some EMEA markets. Contact: Michelle Carroll & Ryan Morinelli
HR Americas go-live on Service Portal
Delivered first phase of People Insights Ecosystem (PIE) using Code Orange data visualization
We successfully leveraged GSK's Code Orange Environment to blend multiple sources of HR data into a scalable and highly available platform for HR Data analytics. This platform provides high levels of privacy, security, governance and maintenance automation to further the Advanced Analytics needs of GSK. Delivered Global Workforce Dashboard with improved visualisations, frequency of updates and self-service analytics capability. Contact: Tom Thistlewaite, Manish Maheshwari and Vikram Singh
Tech Talk: Accelerating delivery in Cloud
We hosted a Tech Talk on Cloud where we discussed our strategy and invited a panel of internal experts to share benefits of our approach and what they are seeing in the market. This move to cloud will enable quicker access to data, securely, and ultimately speed up the time to trial for future solutions for our patient and consumer. Learn more Contact: Kanda Natarajan
The R&D Clinical Control Tower went live in May and provides a single source of truth for clinical study progress at the portfolio and study levels, and will compare study performance against Upper Quartile industry benchmarks later this summer, and country-level metrics towards the end of the year. It is the first application to use end-to-end data via the Clinical Data Fabric directly from source systems. This is part of DDA’s drive towards enabling Upper Quartile performance in Clinical Operations. Learn more Contact: David Gray and Vasiliki Nikolodimou
R&D Clinical Control Tower MVP
DataCon 2021
GSK is committed to improving data literacy across our organisation as we move at pace towards building two, new data-driven organisations. This June, we brought together more than 400 Data & Analytics practitioners from 25 countries across GSK for the first time with our own CET members and internal experts, as well as an array of hands-on workshops, networking and fun activities. Each of the three days of DataCon revolved around a theme (Inspire, Activate, Transform) and was highlighted by an inspirational thought leader (both external and internal) in a keynote broadcast to everyone at GSK, with over 600 viewers. During the event that in total touched more than 1,000 people, we set up 35 cohorts for on-going networking and connectivity to accelerate our D&A ambitions. Learn more Contact: Nicky Walker
Partnering with ClinOps to introduce Agile ways of working to early adopter teams and scale to enable organisation to deliver with agility and pace. Contact: Joss Duggan
Clinical Ops / AAH partnership to help enable ClinOps as an Agile organization
Worked with Priority Asset teams to use Agile to problem solve pain points in the Development lifecycle, identifying potential to cut significant cycle time from studies. Contact: Joss Duggan
Identified reduction of 160-370 days to enroll patients for six studies across five assets
Established Tribe (Agile@Scale) to deliver MVP tools to contribute towards reducing cycle time for patient enrolment. Contact: Joss Duggan
Established first (MVP) tribe to deliver value at scale
Separation & Integration
Integrated markets
All 63 EMEA Pfizer markets are now fully integrated with the JV. Contact: Nail Suleimanov
Cosmos Brazil go-live in May was the final commercial market. This completes all market integrations. Manufacturing cutover the Aprilia (Italy) and Suzhou (China) sites in June, this leaves only Montreal to complete in September to conclude the Pfizer integration. Contact: Paul Donovan
Go/No Go on two Pfizer manufacturing sites as part of Cosmos
Brazil Cosmos commercial ERP cutover
Cosmos/CH Separation
P&S Separation cutover planning is underway
With cutover being a hot topic across the business, our global cutover planning is shaping up nicely. We’re now able to confirm the outage period we need for both new CH and new GSK, when we separate ERP (and any ERP entangled apps) in April 2022. The technical outage for new GSK is two days and for new CH it’s four days, plus a tiered ramp-up of 3-5 days of activity across CH. Contact: David Venter and Divy Anand
Covering all 1200 CH apps, processes (~1126 level 3 processes), infrastructure and cyber-security capabilities for both new CH and new GSK, we have now completed the test framework. This will guide our scoping activity over the coming weeks. Contact: Divy Anand
Completed our Test framework for Tech-led and Business-led (UAT) testing
The last commercial ERP cutover for the CH Cosmos program occurred in Brazil with a successful go-live thanks to a large cross-matrix team of Tech and Commercial leaders. A decision to move to BAU was made for 11th June. Learn more Contact: Paul Donovan
We have successfully deployed foundational infrastructure for all in-scope sites which lays the path for all other infrastructure migration activities. 515 out of 543 TSAs have been exited, reducing the costs GSK pay to Pfizer for on-going support, we have completed the mobile device migration work migrating 57 markets and 2633 devices to GSK, and have completed wiping and disposal or reuse of over 4,000 laptops, moving users to a single device. We’ve also successfully deployed a brand-new CH Azure Cloud hosting environment, built from the ground-up using all new architecture solutions and is a major milestone in the path to separation of GSK into two leading companies. Learn more Contact: Manny Sandhu
We’ve now completed the definitions for all 145 (level 2) business processes involved in Separation, including 39 ‘hotspot’ (entangled) processes. This means we now know what process needs to change and where there’s an impact on our systems, policies and training materials. A brilliant foundation for the work to come in Q3/Q4. Contact: Nicolas Lasalvia Temperley
We’ve defined every business process involved in Separation
Integration
We’ve completed the scoping assessment for all our application integration (for both internal and external ‘end points’). There are over 4,400 electronic interfaces to separate. The next priority is to work out how many we need to test, using our risk-based testing approach, and working with the relevant third parties, through the appropriate business owners. Contact: Divy Anand
Our interface scope is now confirmed
Separation
Business processes
Hotspots
39
145
Innovation at Barnard Castle’s Q Block
Barnard Castle Q Block is a state-of-the art, fully automated paperless manufacturing facility built for the future. Lab Execution System (LES) and electronic Batch Records (eBRS) are the key paperless systems that reduce human error, simplify our processes and help enable Q Block to maximise yield, reduce waste and assure the highest sterile standards. Learn more Contact: Graham McCauley
Beyond delivered the first sessions of its Horizon X Tour – a series of conversations between innovative startups and senior leaders from Tech and the Business. We set out to expose GSK to external innovators and learn from them about the emerging technologies they are working on, in order to enrich and trigger our own innovative thinking. The themes were oriented towards Customer and Consumer Engagement and Manufacturing and Supply Chain topics. GSK participants discussed potential applications to current business priorities, and started gauging interest for further exploration of nine technologies. Beyond is now facilitating the follow-ups between GSK and the startups and working on evolving the event format in order to expand to more parts of the GSK business. Contact: Tatyana Staneva
Beyond Horizon X Tour
Future by Design Masterclass
We delivered the Future by Design Masterclass to 20 senior colleagues across GSK. There was great collaboration with the Institute for the Future (Bob Johansen) and Innosight (Mark Johnson) who were the main presenters of the highly interactive and engaged eight week programme. Our next step will be to support Masterclass graduates on their first “Future by Design” programmes within their respective functions. Contact: Veronica Scotto, Tom Revak and Alexander Pysik
We delivered the first series of Tech and Digital Innovation Demo Days to highlight the innovative technologies being produced by the Tech and Digital Innovation teams around the company. The demos highlighted a wide range of new capabilities designed to deliver value and support GSK’s competitive advantage. The seven demos were attended by 2,413 participants (1,119 unique) and included an active Q&A dialogue as the presenters explained the immediate value and future opportunities. We also built a Demo Day Hub to host all session recordings which gained 493 views post-event. The next series of Demo Days is currently being planned for Autumn 2021. Learn more Contact: Tom Revak and Veronica Scotto
Tech and Digital Innovation Demo Days
Using modern AI/ML techniques and protein language models, we were able to shortlist six candidates by predicting surface exposure and structural stability. This is helping accelerate our discovery process to identify the antigens for polymicrobial AMR – diabetes foot infection. Contact: Sai Jasti
AI&ML techniques identify antigens for Polymicrobial AMR
Digital Twin is a virtual representation that serves as the real-time digital counterpart of a physical object or process. When we used it to support our respiratory supply chain, we optimised the schedules for filling, assembling and packing simultaneously, based on our customer demand. We first started in 2018 and saw improvements to support prioritisation and weighting at our site in Ware. Contact: Graham McCauley
Digital Twin used in PSC Tech
Partnering with Vaccines Tech R&D we have developed the first AS01 engineering lot with digital twin technologies. The twin was able to monitor the process, predict the size of liposomes in real time and propose control actions in case of deviations. This helps us with continuous improvement. Learn more Contact: Sai Jasti and Andy Bonner
Digital Twin used to develop first AS01 engineering lot
We hosted a Tech Talk where a panel of cyber security experts from the Tech Security & Risk team discussed the dramatic increase in cyber, and in particular, ransomware attacks we have experienced across the pharm industry in the last 12 months, in the wake of the COVID crisis, as cyber criminals look to expose vulnerabilities in the way organisations and individuals work and go about their daily lives. Learn more Contact: Michael Doran
The sinister side of cyber security: Ransomware
In April, the Risk Oversight & Compliance Committee (ROCC) instructed TSR to block the ability to attach data files to personal webmail messages (Gmail, Yahoo!, Outlook, Hotmail, AOL and local equivalents), to stop potential GSK data loss. Learn more Contact: Mark Graham and Richard Stewart
Personal webmail blocking
We closed the high volume of Audit memos from Deloitte in the area of Privileged Access and Access Management. We are pleased that we were able to report to ROCC and ARC that GSK Tech and Finance feel this is no longer a significant Sox risk for GSK. Contact: Donna Wilson, Kris Radmar and Bhaps Bagar
Significant reduction of risk in Access audit
We completed of formal Qualification of Code Orange, enabling the business to use it for regulated processes for the first time! This also meant that we had full alignment across Business quality functions for the first time. Contact: Donna Wilson and Caitlin Doyle Weiss
Qualification of Code Orange infrastructure
A complete set of user stories were created for legacy tooling replacements in order to prepare for both new GSK and new Consumer Healthcare. The plan was created to replace AIT, CAMP and Eracent before the end of 2021, improve software vendor audit readiness process and reduce software asset management risk to GSK. Contact: Donna Wilson and Brenda Geary
Completion of SAMPro user stories
